Skip to content

CategoryNotch-1 pathway

Researchers begin to map epigenetic methylation in specific cancer drug resistance.

A team of researchers led by Duke Cancer Institute have identified key events that prompt certain cancer cells to develop resistance to otherwise lethal therapies.  By mapping the points of … Continue Reading Researchers begin to map epigenetic methylation in specific cancer drug resistance.

Translate »